Click Here! Click Here!
 
Click Here!
Search archive       

Surgeons as gatekeepers
Rates of referral for presurgical multidisciplinary assessment in BC

Emotional distress screening in Canadian cancer care
How and where is it being done?

Review of important clinical trials with commentaries by Canadian experts
The 44th Annual Meeting of the American Society of Clinical Oncology
KRAS as a predictive marker in metastatic colorectal cancer

Microsatellite instability and adjuvant therapy for Stage II colon cancer

A prognostic test for early Stage IB–II NSCLC

Cetuximab in advanced NSCLC

Targeted therapies in metastatic breast cancer

Hormonal therapy and targeted agents in metastatic breast cancer

Cover photo: Colon cancer cells • steve Gschmeissner / SPL / PUBLIPHOTO

Trastuzumab in advanced breast cancer

First-line treatment of metastatic renal cell cancer

Second-line treatment of metastatic renal cell cancer

Stage I testicular seminoma

EGFR inhibitors and availability of KRAS testing for metastatic colorectal cancer in Canada

The buck stops here: oncologists’ role in managing expectations


Professional meetings roster
Your calendar dates for essential conferences and symposia


New drugs and indications
A review of recent cancer therapy
approvals in Canada and the US

 

 
 

We welcome your letters and suggestions for future articles.

Please address correspondence
to Owen Dyer, Managing Editor,
at
editors@oncology.com

Click Here! Click Here!
© Parkhurst Publishing Privacy Statement
Legal Terms of Use